Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
53.42
+2.11 (4.11%)
At close: Aug 22, 2025, 4:00 PM
53.20
-0.22 (-0.41%)
After-hours: Aug 22, 2025, 4:23 PM EDT

Palvella Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Selling, General & Admin
11.635.943.084.16
Research & Development
14.928.158.7913.88
Operating Expenses
26.5514.111.8718.04
Operating Income
-26.55-14.1-11.87-18.04
Interest Expense
-5.11-4.32--10.36
Interest & Investment Income
1.44-6.27-
Other Non Operating Income (Expenses)
0.74-0.121.2-0.17
EBT Excluding Unusual Items
-29.48-18.53-4.41-28.58
Other Unusual Items
1.11.123.1-
Pretax Income
-28.38-17.4318.69-28.58
Income Tax Expense
----1.03
Net Income
-28.38-17.4318.69-27.55
Preferred Dividends & Other Adjustments
-0.39-14.81-
Net Income to Common
-27.99-17.433.88-27.55
Shares Outstanding (Basic)
7226
Shares Outstanding (Diluted)
7226
Shares Change (YoY)
19.89%24.08%-68.63%-
EPS (Basic)
-4.08-7.832.19-4.82
EPS (Diluted)
-4.08-7.832.17-4.82
EBIT
-26.55-14.1-11.87-18.04
Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q